BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 26114818)

  • 1. Long-Term Results of the Boston Keratoprosthesis for Unilateral Corneal Disease.
    Kosker M; Suri K; Rapuano CJ; Ayres BD; Nagra PK; Raber IM; Hammersmith KM
    Cornea; 2015 Sep; 34(9):1057-62. PubMed ID: 26114818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boston type 1 keratoprosthesis outcomes in ocular burns.
    Magalhães FP; Hirai FE; de Sousa LB; de Oliveira LA
    Acta Ophthalmol; 2013 Sep; 91(6):e432-6. PubMed ID: 23406295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure.
    Kang JJ; de la Cruz J; Cortina MS
    Cornea; 2012 Dec; 31(12):1436-40. PubMed ID: 22367042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Boston type I keratoprosthesis: improving outcomes and expanding indications.
    Aldave AJ; Kamal KM; Vo RC; Yu F
    Ophthalmology; 2009 Apr; 116(4):640-51. PubMed ID: 19243830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boston type 1 keratoprosthesis for primary congenital glaucoma.
    Haugsdal JM; Goins KM; Greiner MA; Kwon YH; Alward WL; Wagoner MD
    Br J Ophthalmol; 2016 Mar; 100(3):328-31. PubMed ID: 26206789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure.
    Fadous R; Levallois-Gignac S; Vaillancourt L; Robert MC; Harissi-Dagher M
    Br J Ophthalmol; 2015 Dec; 99(12):1664-8. PubMed ID: 26034079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 1 Boston keratoprosthesis: outcomes at two Canadian centres.
    Noel CW; Isenberg J; Goldich Y; Conlon R; Teichman J; Rubinger DA; Weinberg TA; Slomovic J; Chan CC; Rootman DS; Baig KM; Slomovic AR
    Can J Ophthalmol; 2016 Apr; 51(2):76-82. PubMed ID: 27085262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boston type 1 keratoprosthesis: the university of california davis experience.
    Bradley JC; Hernandez EG; Schwab IR; Mannis MJ
    Cornea; 2009 Apr; 28(3):321-7. PubMed ID: 19387235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vision retention in early versus delayed glaucoma surgical intervention in patients with Boston Keratoprosthesis type 1.
    Lin M; Bhatt A; Haider A; Kim G; Farid M; Schmutz M; Mosaed S
    PLoS One; 2017; 12(8):e0182190. PubMed ID: 28777800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Boston keratoprosthesis in the management of corneal limbal stem cell deficiency.
    Sejpal K; Yu F; Aldave AJ
    Cornea; 2011 Nov; 30(11):1187-94. PubMed ID: 21885964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of pars plana glaucoma drainage implant in Boston type 1 keratoprosthesis surgery.
    Huh ES; Aref AA; Vajaranant TS; de la Cruz J; Chau FY; Cortina MS
    J Glaucoma; 2014 Jan; 23(1):e39-44. PubMed ID: 24370810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a low-cost design keratoprosthesis in end-stage corneal disease: a preliminary study.
    Sharma N; Falera R; Arora T; Agarwal T; Bandivadekar P; Vajpayee RB
    Br J Ophthalmol; 2016 Mar; 100(3):323-7. PubMed ID: 26271267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Outcomes of the Boston Type I Keratoprosthesis in the Management of Corneal Limbal Stem Cell Deficiency.
    Aravena C; Bozkurt TK; Yu F; Aldave AJ
    Cornea; 2016 Sep; 35(9):1156-64. PubMed ID: 27387566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boston Type 1 Keratoprosthesis: Visual Outcomes, Device Retention, and Complications.
    Goins KM; Kitzmann AS; Greiner MA; Kwon YH; Alward WL; Ledolter J; Wagoner MD
    Cornea; 2016 Sep; 35(9):1165-74. PubMed ID: 27191675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of visual outcomes following Boston type 1 keratoprosthesis implantation.
    Ahmad S; Akpek EK; Gehlbach PL; Dunlap K; Ramulu PY
    Am J Ophthalmol; 2015 Apr; 159(4):739-47. PubMed ID: 25555801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boston keratoprosthesis type I in the elderly.
    Homayounfar G; Grassi CM; Al-Moujahed A; Colby KA; Dohlman CH; Chodosh J
    Br J Ophthalmol; 2017 Apr; 101(4):514-518. PubMed ID: 27381593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual improvement after cultivated oral mucosal epithelial transplantation.
    Sotozono C; Inatomi T; Nakamura T; Koizumi N; Yokoi N; Ueta M; Matsuyama K; Miyakoda K; Kaneda H; Fukushima M; Kinoshita S
    Ophthalmology; 2013 Jan; 120(1):193-200. PubMed ID: 23084239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International Outcomes of the Boston Type I Keratoprosthesis in Stevens-Johnson Syndrome.
    Alexander JK; Basak SK; Padilla MD; Yu F; Aldave AJ
    Cornea; 2015 Nov; 34(11):1387-94. PubMed ID: 26382898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term visual outcomes of Boston type 1 keratoprosthesis implantation.
    Dunlap K; Chak G; Aquavella JV; Myrowitz E; Utine CA; Akpek E
    Ophthalmology; 2010 Apr; 117(4):687-92. PubMed ID: 20096462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.